OHSU in the news

The first steps in gene therapy for achromatopsia

Opthalmology Times May 14, 2021
Mark Pennesi, M.D., Ph.D., says, preliminary results of two Phase 1/2 clinical trials evaluating experimental gene therapy treatments for achromatopsia, which impairs color vision, indicate the treatments can produce “encouraging signs of biologic activity.”

OHSU COVID-19 vaccination clinic in Hillsboro focuses on Latinx community

KATU-TV May 13, 2021
In coverage of a bilingual vaccination event, which was held at the Hillsboro Stadium to help improve vaccine access for the local Latino community, Leda Garside, M.B.A., R.N., says: “As health care workers, we are going to do everything possible so people feel comfortable during the process of getting the vaccine.”

Fighting for fertility

NOVA May 12, 2021
Shawn Chavez, Ph.D., is featured in a NOVA documentary about the challenges associated with in vitro fertilization.

Many resuscitated arrests don't have an underlying cardiac cause

tctMD May 12, 2021
In a Journal of the American College of Cardiology editorial about new research exploring the causes of resituated sudden cardiac arrests, Eric Stecker, M.D., and Babak Nazer, M.D., write “fully 85% of individuals who experience cardiac arrest due to a verified cardiac etiology will die, causing more premature loss of life than most cancers. This emphasizes the importance of efforts to prevent the onset of cardiovascular disease through treatment of the most-important modifiable risk factors: hypertension, elevated low-density lipoprotein, diet/obesity, and smoking.”
See more stories